# FDA Inspection 1266061 - Symbiosis Pharmaceutical Services Limited - January 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/symbiosis-pharmaceutical-services-limited/9cc39e9a-12c9-4594-9c1d-2be855e491f6
Source feed: FDA_Inspections

> FDA Inspection 1266061 for Symbiosis Pharmaceutical Services Limited on January 31, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266061
- Company Name: Symbiosis Pharmaceutical Services Limited
- Inspection Date: 2025-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/symbiosis-pharmaceutical-services-limited/154cac8a-804c-4594-88ec-04aa67984fbc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d